The clinical impacts of molecular subtyping by multigene assay on hormone receptor-positive breast cancers
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the Chinese Medical Association"
DOI: 10.1097/jcma.0000000000000657
Abstract: Background: Multigene assays, such as MammaPrint and BluePrint, provide additional information other than conventional immunohistochemistry (IHC) to help making decision of treatment. This study aims to compare the clinical correlation between molecular subtyping (MS) versus… read more here.
Keywords: receptor positive; hormone receptor; molecular subtyping; positive breast ... See more keywords
Practical Consequences Resulting from the Analysis of a 21-Multigene Array in the Interdisciplinary Conference of a Breast Cancer Center
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Breast Cancer"
DOI: 10.1155/2018/2047089
Abstract: During the multidisciplinary planning of postoperative therapy after breast cancer, borderline cases can arise with no clear rationale for or against adjuvant chemotherapy. In 50 hormone- receptor-positive, Her2neu-negative carcinomas of the breast with no or… read more here.
Keywords: test; breast; breast cancer; multigene ... See more keywords
Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14112805
Abstract: Simple Summary Adrenocortical carcinoma (ACC) is a rare but aggressive cancer with a high rate of fatality. Accurate prediction of cancer relapse following therapy and prognosis (fatality) is essential to improve patient management. This research… read more here.
Keywords: prognosis; sig27var25 sigiqvar8; sigcmbnvar5 sigcmbn; relapse ... See more keywords